![FDA, FTC and DOJ Enforcement of Medical Device Regulations FDA, FTC and DOJ Enforcement of Medical Device Regulations](https://www.fdanews.com/ext/resources/Book-Covers-2/BFFDEMDR-COVER.png?height=200&t=1685733565&width=200)
Home » Eli Lilly Starts World’s First Human Trial of Antibody for COVID-19
Eli Lilly Starts World’s First Human Trial of Antibody for COVID-19
![shot vaccine blue](https://www.fdanews.com/ext/resources/test/Device_Images/shot-blue-bkgrd.jpg?t=1622221340&width=430)
Eli Lilly has dosed its first patients in the world’s first trial of an investigational antibody designed to treat COVID-19.
The phase 1 trial of LY-CoV555 will investigate the safety and tolerability of a single dose administered to hospitalized COVID-19 patients.
LY-CoV555 is the first investigational treatment to emerge from the company’s development collaboration with AbCellera. Results of the trial are anticipated by the end of the month.
Upcoming Events
-
21Oct